Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus.
Journal Information
Full Title: Aliment Pharmacol Ther
Abbreviation: Aliment Pharmacol Ther
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of personal interests: MR, MF, EM, GDC, SZ, DM, PB, MC: no disclosures; ES has received lecture or consultancy fees from Abbvie, Alfasigma, Amgen, Aurora Pharma, Bristol‐Myers Squibb, EG Stada Group, Fresenius Kabi, Grifols, Janssen, Innovamedica, Malesci, Medtronic, Merck & Co, Reckitt Benckiser, Sandoz, Shire, SILA, Sofar, Takeda, Unifarco."
"Funding interests: no funds to declare."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025